- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
March 26, 2024Ronald Schutz, Brendan Johnson Named to Forbes Top 200 Lawyers in the United States
-
March 21, 2024Robins Kaplan Firm Members Appointed to Law360 Editorial Boards
-
March 20, 2024Brandon Vaughn Inducted into The International Society of Barristers
-
April 5, 2024Mass Torts Made Perfect
-
April 17, 2024American Antitrust Institute Virtual CLE Lunch & Learn
-
May 2-3, 2024ACI Advanced Forum on Managed Care Disputes and Litigation
-
March 22, 2024‘In re Cellect’:
-
March 14, 2024How Many Cases Have You Tried to a Verdict?
-
March 2024Do We Have to Share That Information? Attorney-Client Privilege in the Multi-Entity Context
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Read our attorneys' take on the latest news and trends in the legal and business industries.
ANDA Approvals
New Drug Applications and 505(b)(2) Applications
Third Quarter
This chart tracks the date, drug, reference-listed company, and applicant of Abbreviated New Drug Applications and 505(b)(2) Applications receiving final approval by the FDA.
Approval Date | Reference Listed Drug | Generic Drug Name | NDA Holder | ANDA Applicant |
---|---|---|---|---|
7/01/2021 | Truvada | Emtricitabine / Tenofovir Disoproxil Fumarate | Gilead | Zydus Pharms |
7/01/2021 | Docetaxel | Docetaxel | Hospira | Gland Pharma |
7/01/2021 | Mucinex DM | Guaifenesin / Dextromethorphan Hydrobromide | Indivior | Sun |
7/02/2021 | Lyrica CR | Pregabalin | Pfizer | Mylan |
7/02/2021 | Cedazuridine | Decitabine | Otsuka | Meitheal |
7/06/2021 | Invega Sustenna | Paliperidone Palmitate | Johnson & Johnson | Teva |
7/06/2021 | Lyrica CR | Pregabalin | Pfizer | Alvogen |
7/06/2021 | Robinul | Glycopyrrolate | AH Robins | Meitheal |
7/06/2021 | Deltasone | Prednisone | Pharmacia / Upjohn | Novitium Pharma |
7/7/2021 | Norpramin | Desipramine HCl | Validus | Alembic |
7/7/2021 | Lyrica | Pregabalin | Upjohn | Apotex |
7/8/2021 | Tarceva | Erlotinib HCl | OSI Pharma | Alembi |
7/9/2021 | Brilinta | Ticagrelor | AstraZeneca | Mylan |
7/9/2021 | Trileptal | Oxcarbazepine | Novartis | Akorn |
7/9/2021 | Mycamine | Micafungin Sodium | Astellas | Hikma |
7/9/2021 | Mycamine | Micafungin Sodium | Astellas | Jiangsu Hansoh Pharm |
7/12/2021 | Promethazine Hydrochloride Plain | Promethazine HCl | ANI Pharma | Quagen |
7/12/2021 | Nitropress | Sodium Nitroprusside | AbbVie | Be Pharms |
7/13/2021 | Imitrex | Sumatriptan Succinate | Glaxo | Caplin |
7/13/2021 | Lioresal | Baclofen | Novartis | Aurobindo |
7/14/2021 | Lipitor | Atorvastatin Calcium | Upjohn | Dr Reddys Labs |
7/15/2021 | Arthrotec | Diclofenac Sodium / Misoprostol | Pfizer | Micro Labs |
7/15/2021 | Estrace | Estradiol | AbbVie | Prasco Labs |
7/15/2021 | Tobradex | Tobramycin / Dexamethasone | Novartis | Amneal |
7/15/2021 | Apriso | Mesalamine | Bausch & Lomb | Alkem |
7/15/2021 | Lyrica | Pregabalin | Upjohn | Changzhou Pharm |
7/16/2021 | Samsca | Tolvaptan | Otuska | Hetero Labs |
7/16/2021 | Lioresal | Baclofen | Novartis | Beximco Pharms |
7/19/2021 | Adalat CC | Nifedipine | Alvogen | Aurobindo |
7/20/2021 | Vimovo | Naproxen / Esomeprazole Magnesium | Horizon | Mylan |
7/20/2021 | Taytulla | Norethindrone Acetate / Ethinyl Estradiol / Ferrous Fumarate | AbbVie | Amneal |
7/26/2021 | Eliquis | Apixaban | Bristol-Myers Squibb | Breckenridge |
7/26/2021 | Ery-Tab | Erythromycin | Arbor | Torrent |
7/26/2021 | Atropine Sulfate | Atropine Sulfate | Hospira | Accord Healthcare |
7/26/2021 | Haldol | Haloperidol Decanoate | Janssen | Meitheal |
7/27/2021 | Daraprim | Pyrimethamine | Vyera | Alvogen / Fera |
7/27/2021 | Emla | Lidocaine / Prilocaine | Teva | Acrux |
7/28/2021 | Sabril | Vigabatrin | Lundbeck | Specgx |
7/28/2021 | Actigall | Ursodiol | AbbVie | Vgyaan |
7/29/2021 | Sabril | Vigabatrin | Lundbeck | Navisci |
7/29/2021 | CellCept | Mycophenolate Mofetil | Roche | Lannett |
7/29/2021 | Emend | Fosaprepitant Dimeglumine | Merck | Aspiro |
7/29/2021 | Paraflex | Chlorzoxazone | Ortho McNeil | Senores Pharms |
7/29/2021 | Faslodex | Fulvestrant | AstraZeneca | Zydus |
7/30/2021 | Potassium Chloride 10meq in Dextrose 5% and Sodium Chloride 0.225% in Plastic Container | Potassium Chloride 10meq in Dextrose 5% and Sodium Chloride 0.225% in Plastic Container | ICU Medical | Fresenius Kabi |
7/30/2021 | Potassium Chloride 20meq in Dextrose 5% and Sodium Chloride 0.225% in Plastic Container | Potassium Chloride 20meq in Dextrose 5% and Sodium Chloride 0.225% in Plastic Container | ICU Medical | Fresenius Kabi |
8/02/2021 | Detrol | Tolterodine Tartrate | Pfizer | Hetero Labs |
8/02/2021 | BiCNU | Carmustine | Emcure | Meitheal |
8/03/2021 | Belbuca | Buprenorphine HCl | Biodelivery | Alvogen |
8/03/2021 | Duexis | Ibuprofen / Famotidine | Horizon | Alkem |
8/03/2021 | Nicorette | Nicotine Polacrilex | Glaxo | Aurobindo |
8/03/2021 | Glumetza | Metformin HCl | Santarus | Amta |
8/04/2021 | Kadian | Morphine Sulfate | AbbVie | Nortec Dev |
8/04/2021 | Anafranil | Clomipramine HCl | SpecGx | Alembic |
8/04/2021 | Hexadrol | Dexamethasone / Sodium Phosphate | Aspen Global | Gland Pharma |
8/06/2021 | Effexor XR | Venlafaxine HCl | Upjohn | Yichang Humanwell |
8/9/2021 | Cuvposa | Glycopyrrolate | Merz | Par |
8/9/2021 | Durezol | Difluprednate | Novartis | Cipla |
8/9/2021 | Namenda XR | Memantine HCl | AbbVie | Aurobindo |
8/10/2021 | Epaned O.S. | Enalapril Maleate | Silver | Bionpharma |
8/11/2021 | Chantix | Varenicline | Pfizer | Par |
8/11/2021 | Aggrenox | Aspirin / Dipyridamole | Boehringer-Ingelheim | Micro Labs |
8/11/2021 | Imodium | Loperamide HCl | Johnson & Johnson | Strides Pharma |
8/11/2021 | Glucophage XR | Metformin HCl | EMD Serono | Unichem |
8/11/2021 | Paxil CR | Paroxetine HCl | Glaxo | Sinotherapeutics |
8/12/2021 | Colcrys | Colchicine | Takeda | Par |
8/12/2021 | Apriso | Mesalamine | Bausch & Lomb | Zydus |
8/13/2021 | Colcrys | Colchicine | Takeda | Hetero Labs |
8/13/2021 | Syprine | Trientine HCl | Bausch & Lomb | Eci Pharms |
8/13/2021 | Clindagel | Clindamycin Phosphate | Bausch & Lomb | Solaris Pharma |
8/13/2021 | Faslodex | Fulvestrant | AstraZeneca | Xiromed |
8/13/2021 | Lupron | Leuprolide Acetate | AbbVie | Vgyaan |
8/13/2021 | Daraprim | Pyrimethamine | Vyera | Teva |
8/16/2021 | Sutent | Sunitinib Malate | Pfizer | Sun Pharm |
8/16/2021 | Tegretol | Carbamazepine | Novartis | Vgyaan |
8/17/2021 | Mykacet | Nystatin / Triamcinolone Acetonide | Cossette | Macleod |
8/18/2021 | Trandate | Labetalol HCl | Alvogen | Rubicon |
8/19/2021 | Cuprimine | Penicillamine | Bausch & Lomb | Invagen Pharms |
8/19/2021 | Xeljanz XR | Tofacitinib | Pfizer | Zydus |
8/19/2021 | Diamox | Acetazolamide | Teva | Rubicon |
8/20/2021 | Symmetrel | Amantadine HCl | Endo | Invatech |
8/20/2021 | Rubramin PC | Cyanocobalamin | Bristol-Myers Squibb | Xiromed |
8/20/2021 | Zaroxolyn | Metolazone | Lannett | Rubicon |
8/23/2021 | Cuprimine | Penicillamine | Bausch | Aggrega |
8/24/2021 | Latuda | Lurasidone HCl | Sunovion | Dr Reddys Labs |
8/24/2021 | Aramine | Metaraminol Bitartrate | Merck | Slayback |
8/24/2021 | Cubicin | Daptomycin | Merck | Qilu |
8/25/2021 | Ortho Evra | Onsura | Janssen | Teva |
8/25/2021 | Tylenol | Acetaminophen | Johnson & Johnson | Marksans Pharma |
8/26/2021 | Topamax | Topiramate | Janssen | Ascent Pharms |
8/27/2021 | Paxil CR | Paroxetine HCl | Apotex | Cadila Pharms |
8/30/2021 | Jentadueto | Linagliptin / Metformin HCl | Boehringer-Ingelheim | Sunshine |
8/30/2021 | Protonix | Pantoprazole Sodium | Wyeth | ACIC Pharms |
8/30/2021 | Tamiflu | Oseltamivir Phosphate | Roche | Aptapharma |
8/30/2021 | Syprine | Trientine HCl | Bausch | Accord Healthcare |
8/31/2021 | Tradjenta | Linagliptin | Boehringer-Ingelheim | Sunshine |
8/31/2021 | Bactroban | Mupirocin | Glaxo | Encube |
9/02/2021 | Cubicin | Daptomycin | Merck | Eugia Pharma |
9/02/2021 | Lipitor | Atorvastatin Calcium | Upjohn | August |
9/03/2021 | Axiron | Testosterone | Eli Lilly | TWi Pharms |
9/03/2021 | Metrogel | Metronidazole | Galderma | Aleor Dermaceuticals |
9/03/2021 | Aralen | Chloroquine Phosphate | Sanofi Aventis | Suven Pharms |
9/03/2021 | Precedex | Dexmedetomidine HCl | Hospira | Piramal |
9/03/2021 | Paxil | Paroxetine HCl | Apotex | Novitium Pharma |
9/7/2021 | Integrilin | Eptifibatide | Schering | Shuangcheng |
9/7/2021 | Evekeo | Amphetamine Sulfate | Arbor | Rhodes Pharms |
9/7/2021 | Normodyne | Labetalol HCl | Schering | Caplin |
9/8/2021 | Xylocaine with epinephrine | Lidocaine HCl / Epinephrine | Fresenius Kabi | B Braun Medical |
9/8/2021 | Cerdelga | Eliglustat Tartrate | Sanofi | Aizant |
9/8/2021 | Halog | Halcinonide | Sun | Glasshouse Pharms |
9/10/2021 | Imodium | Loperamide HCl / Simethicone | Johnson & Johnson | Bionpharma |
9/13/2021 | Atripla | Efavirenz / Emtricitabine / Tenofovir Disoproxil Fumarate | Gilead | Macleods |
9/13/2021 | Motrin | Ibuprofen | McNeil | Alkem |
9/17/2021 | Trintellix | Vortioxetine Hydrobromide | Takeda | Zydus |
9/17/2021 | Quinaglute ER | Quinidine Gluconate | Bayer | Eywa |
9/17/2021 | Ofirmev | Acetaminophen | Mallinckrodt | Baxter Healthcare |
9/20/2021 | Evoclin | Clindamycin Phosphate | Mylan | Glenmark |
9/20/2021 | Tricor | Fenofibrate | AbbVie | Aurobindo |
9/20/2021 | Dacogen | Decitabine | Otsuka | Eugia Pharma |
9/21/2021 | Medrol | Methylprednisolone | Pfizer | Amneal |
9/21/2021 | Teflaro | Ceftaroline Fosamil | AbbVie | Apotex |
9/21/2021 | Otezla | Apremilast | Amgen | Alkem |
9/21/2021 | Otezla | Apremilast | Amgen | Zydus |
9/21/2021 | Absorica | Isotretinoin | Sun | Upsher Smith Labs |
9/22/2021 | Compazine | Prochlorperazine Edisylate | Glaxo | Gland Pharma |
9/23/2021 | Myfortic | Mycophenolic Acid | Novartis | Alkem |
9/23/2021 | Mirvaso | Brimonidine Tartrate | Galderma | Padagis |
9/23/2021 | Butrans | Buprenorphine | Purdue | Aveva |
9/23/2021 | Sabril | Vigabatrin | Lundbeck | Dexcel Pharma |
9/24/2021 | Aubagio | Teriflunomide | Sanofi | Breckenridge |
9/28/2021 | Compazine | Prochlorperazine Edisylate | Glaxo | Viwit Pharm |
9/29/2021 | Fortamet | Metformin HCl | Andrx | TWi Pharms |
9/29/2021 | Sabril | Vigabatrin | Lundbeck | Aurobindo |
9/29/2021 | Adderall XR | Detroamp Saccharate / Amp Aspartate / Dextroamp Sulfate / Amp Sulfate | Takeda | Ascent Pharms |
9/30/2021 | Zomig | Zolmitriptan | AstraZeneca | Padagis |
9/30/2021 | Tegretol XR | Carbamazepine | Novartis | Anbison Lab |
GENERICally Speaking Hatch Waxman Bulletin
GENERICally Speaking Hatch Waxman Bulletin
READ MORE Related Publications
Fourth Quarter
GENERICally Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
December 29, 2023
Corcept Therapeutics, Inc. v. Teva Pharms. USA, Inc.
GENERICally Speaking Hatch Waxman Bulletin
December 13, 2023
Acadia Pharms. Inc. v. Aurobindo Pharma Ltd.
GENERICally Speaking Hatch Waxman Bulletin
December 7, 2023
H. Lundbeck A/S v. Lupin Ltd.
GENERICally Speaking Hatch Waxman Bulletin
November 7, 2023
Eisai R&D Mgmt. Co., Ltd. v. Dr Reddy’s Labs., Inc.
GENERICally Speaking Hatch Waxman Bulletin
Related News
October 14, 2022
September 9, 2022
Back to Top
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.